• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?

    7/9/24 1:47:10 PM ET
    $ALB
    $AMD
    $ARM
    $AVGO
    Major Chemicals
    Industrials
    Semiconductors
    Technology
    Get the next $ALB alert in real time by email

    The S&P 500 index climbed to new all-time highs, rising 0.3% during Tuesday’s session, aiming for a potential sixth consecutive positive close and remaining resilient after Fed Chair Jerome Powell‘s testimony before the Senate Banking Committee.

    Powell used both hawkish tones – stating that it is not yet appropriate to cut rates until greater confidence on the 2% target is achieved – and dovish tones, noting recent progress and warning that a weakening labor market could be a significant factor for a rate cut.

    Markets are looking ahead with confidence to the upcoming June inflation report, due this Thursday, which could solidify the already high expectations for a rate cut in September.

    Financials were the top-performing sector on Tuesday, after Reuters reported that the Federal Reserve is considering revising a key rule that could save the nation's largest banks billions in capital.

    Investors also anticipate the upcoming banking sector earnings report with three major banks – JPMorgan Chase & Co. (NYSE:JPM), Citigroup Inc. (NYSE:C), and Wells Fargo & Co. (NYSE:WFC) – set to announce results on Friday.

    Commodities were broadly softer, likely impacted by the second consecutive surge of a broader U.S. dollar basket and rising Treasury yields. Natural gas rose again by over 1% following supply disruptions caused by Hurricane Beryl.

    Bitcoin (CRYPTO: BTC) rose 1.8% to $57,800.

    Elsewhere, French stocks, as tracked by the iShares MSCI France Index Fund (NYSE:EWQ), tumbled 1.6%, reflecting negative investor sentiment after left-wing parties’ election gain.

    Tuesday’s Performance In Major US Indices, ETFs

    Major IndicesPrice1-day %chg
    Dow Jones39,474.270.3%
    S&P 5005,590.710.3%
    Nasdaq 10020,465.040.1%
    Russell 20002,040.200.0%
    Updated at 1:05 PM ET

    According to Benzinga Pro data:

    • The SPDR S&P 500 ETF Trust (NYSE:SPY) was 0.3% higher to $557.01.
    • The SPDR Dow Jones Industrial Average (NYSE:DIA) was 0.4% higher to $394.89.
    • The tech-heavy Invesco QQQ Trust (ARCA: QQQ) was up 0.1% to $497.83.
    • Sector-wise, the Financials Select Sector SPDR Fund (NYSE:XLF) outperformed, up by 1.4%, while the Technology Select Sector SPDR Fund (NYSE:XLK) lagged, falling 0.4%.

    Tuesday’s Stock Movers

    • Tesla Inc. (NASDAQ:TSLA) rose about 4%, eyeing the 10th straight day of rally and topping gains within mega-cap stocks.
    • Citigroup Inc., Goldman Sachs Inc. (NYSE:GS) and Bank of America Corp. (NYSE:BAC) each rallied by about 2.7%, and JPMorgan rose 1.8%, in response to the positive news on potentially lower capital buffer requirements.
    • Semiconductors weakened across the board Tuesday. Industry giants such as Arm Holdings plc (NYSE:ARM), Broadcom Inc. (NYSE:AVGO) and Advanced Micro Devices Inc. (NASDAQ:AMD) fell by about 2% each.
    • Incyte Corp. (NASDAQ:INCY) and Vestis Corp. (NYSE:VSTS) saw their shares rise by over 4.5% and 7%, respectively, following the announcement of their earnings report dates on July 30 and Aug. 7.
    • Albemarle Corp. (NYSE:ALB) fell 6.7%, on track to achieve lows last seen in October 2020, as lithium prices continue to ease.

    Read Next:

    • Trump’s Deregulation Agenda: Oil & Gas, Defense, And Finance Stocks May Benefit From Loose Rules, Goldman Sachs Says

    Image created using artificial intelligence via Midjourney.

    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB
    $AMD
    $ARM
    $AVGO

    CompanyDatePrice TargetRatingAnalyst
    Albemarle Corporation
    $ALB
    2/17/2026$190.00Neutral → Buy
    BofA Securities
    Broadcom Inc.
    $AVGO
    2/13/2026$335.00Neutral
    DA Davidson
    Advanced Micro Devices Inc.
    $AMD
    2/13/2026$220.00Neutral
    DA Davidson
    Wells Fargo & Company
    $WFC
    2/13/2026$85.00Underperform → Neutral
    Robert W. Baird
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Arm Holdings plc
    $ARM
    2/5/2026Neutral → Buy
    New Street
    Incyte Corp.
    $INCY
    2/5/2026$135.00Buy
    H.C. Wainwright
    JP Morgan Chase & Co.
    $JPM
    2/3/2026$280.00Underperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ALB
    $AMD
    $ARM
    $AVGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for JAKAFI issued to INCYTE CORP

    Submission status for INCYTE CORP's drug JAKAFI (SUPPL-25) with active ingredient RUXOLITINIB PHOSPHATE has changed to 'Approval' on 09/27/2021. Application Category: NDA, Application Number: 202192, Application Classification: Labeling

    9/28/21 5:20:01 AM ET
    $INCY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    FDA Approval for JAKAFI issued to INCYTE CORP

    Submission status for INCYTE CORP's drug JAKAFI (SUPPL-23) with active ingredient RUXOLITINIB PHOSPHATE has changed to 'Approval' on 09/22/2021. Application Category: NDA, Application Number: 202192, Application Classification: Efficacy

    9/23/21 5:11:12 AM ET
    $INCY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    FDA Approval for OPZELURA issued to INCYTE CORP

    Submission status for INCYTE CORP's drug OPZELURA (ORIG-1) with active ingredient RUXOLITINIB has changed to 'Approval' on 09/21/2021. Application Category: NDA, Application Number: 215309, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    9/22/21 11:16:23 AM ET
    $INCY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ALB
    $AMD
    $ARM
    $AVGO
    SEC Filings

    View All

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/20/26 5:24:43 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-K filed by Citigroup Inc.

    10-K - CITIGROUP INC (0000831001) (Filer)

    2/20/26 5:06:54 PM ET
    $C
    Major Banks
    Finance

    SEC Form FWP filed by Citigroup Inc.

    FWP - CITIGROUP INC (0000831001) (Subject)

    2/20/26 4:52:29 PM ET
    $C
    Major Banks
    Finance

    $ALB
    $AMD
    $ARM
    $AVGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bank Of America Corp /De/ bought $4,303 worth of shares (343 units at $12.55) and sold $4,202 worth of shares (343 units at $12.25) (SEC Form 4)

    4 - BANK OF AMERICA CORP /DE/ (0000070858) (Reporting)

    1/28/26 1:23:38 PM ET
    $BAC
    Major Banks
    Finance

    Director You Harry L. bought $325,129 worth of shares (1,000 units at $325.13), increasing direct ownership by 3% to 36,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    12/22/25 5:34:40 PM ET
    $AVGO
    Semiconductors
    Technology

    Large owner Bank Of America Corp /De/ bought $10,319 worth of shares (1,000 units at $10.32) and sold $10,540 worth of shares (1,000 units at $10.54) (SEC Form 4)

    4 - BANK OF AMERICA CORP /DE/ (0000070858) (Reporting)

    12/22/25 5:14:47 PM ET
    $BAC
    Major Banks
    Finance

    $ALB
    $AMD
    $ARM
    $AVGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle upgraded by BofA Securities with a new price target

    BofA Securities upgraded Albemarle from Neutral to Buy and set a new price target of $190.00

    2/17/26 8:01:23 AM ET
    $ALB
    Major Chemicals
    Industrials

    DA Davidson initiated coverage on Broadcom with a new price target

    DA Davidson initiated coverage of Broadcom with a rating of Neutral and set a new price target of $335.00

    2/13/26 8:31:21 AM ET
    $AVGO
    Semiconductors
    Technology

    DA Davidson initiated coverage on Advanced Micro Devices with a new price target

    DA Davidson initiated coverage of Advanced Micro Devices with a rating of Neutral and set a new price target of $220.00

    2/13/26 8:31:11 AM ET
    $AMD
    Semiconductors
    Technology

    $ALB
    $AMD
    $ARM
    $AVGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    24 Merrill Advisors Recognized on Financial Planning's Top 40 Brokers Under 40 List

    Merrill Leads List With Most Advisors Named for Seventh Consecutive YearNEW YORK, Feb. 20, 2026 /PRNewswire/ -- Financial Planning recognized 24 Merrill Wealth Management and Merrill Private Wealth Advisors on its annual Top 40 Brokers Under 40. For the seventh consecutive year, Merrill has had more advisors on the list than any other firm underscoring the strength of Merrill's talent and the company's commitment to advisor development at every stage of their careers. (Rankings published February 10, 2026, based on data as of September 30, 2025.) "We're proud of these advisors a

    2/20/26 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    Wells Fargo Updates 2026 Earnings Release Date Information

    Wells Fargo & Company (NYSE:WFC) today updated its expected earnings release dates and conference call information for 2026. For each of the earnings dates below, financial results will be released at approximately 7:00 a.m. Eastern time, and the live conference call will be at 10:00 a.m. Eastern time. Confirmation of these calls, as well as details on how to listen, will be provided before the scheduled release dates. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260220255811/en/Exterior view of a Wells Fargo branch along a city sidewalk with trees and passing traffic. (Photo: Wells Fargo) Expected earnings release dates for 2

    2/20/26 8:00:00 AM ET
    $WFC
    Major Banks
    Finance

    Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

    The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, supported by rising prevalence. Additionally, the launch of emerging therapies such as RINVOQ (AbbVie), Bempikibart (Q32 Bio), Coacillium (Legacy Healthcare), ALM 223 (Almirall), Amlitelimab (Sanofi), HCW9302 (HCW Biologics), ALY-101 (ALYS Pharmaceuticals), DR-01 (Dren Bio), Rezpegaldesleukin (Nektar Therapeutics), and others will further propel the market growth.LAS VEGAS, Feb. 19, 2026 /PRNewswire/ -- Recently published Alopecia Areata Market Insights report includes a comprehensive understanding of current treatment practices, alopecia ar

    2/19/26 5:31:00 PM ET
    $ABBV
    $HCWB
    $INCY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Commercial Physical & Biological Resarch

    $ALB
    $AMD
    $ARM
    $AVGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pertz Douglas A was granted 18,253 shares, increasing direct ownership by 6% to 340,263 units (SEC Form 4)

    4 - Vestis Corp (0001967649) (Issuer)

    2/20/26 5:22:52 PM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    Director Mckee Lynn was granted 18,253 shares, increasing direct ownership by 11% to 183,235 units (SEC Form 4)

    4 - Vestis Corp (0001967649) (Issuer)

    2/20/26 5:21:40 PM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    Director Burke Richard L. Jr. was granted 18,253 shares, increasing direct ownership by 38% to 66,365 units (SEC Form 4)

    4 - Vestis Corp (0001967649) (Issuer)

    2/20/26 5:20:27 PM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    $ALB
    $AMD
    $ARM
    $AVGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Citigroup Inc.

    SC 13D - CITIGROUP INC (0000831001) ()

    1/5/94 12:00:00 AM ET
    $C
    Major Banks
    Finance

    Amendment: SEC Form SC 13D/A filed by Bank of America Corporation

    SC 13D/A - BANK OF AMERICA CORP /DE/ (0000070858) (Filed by)

    12/13/24 4:29:10 PM ET
    $BAC
    Major Banks
    Finance

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    $AMD
    $ARM
    $AVGO
    Leadership Updates

    Live Leadership Updates

    View All

    AMD Hires Ariel Kelman as Chief Marketing Officer

    SANTA CLARA, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Today AMD (NASDAQ:AMD) announced that Ariel Kelman has been appointed Senior Vice President and Chief Marketing Officer, effective immediately. Kelman will lead the AMD global marketing organization, overseeing brand, communications, events, developer relations and go-to-market strategy. Kelman will report to Ruth Cotter, Senior Vice President and Chief Administrative Officer, and will work closely with the AMD executive team to deepen engagement with customers, partners, developers and the broader technology ecosystem as AMD continues to scale its product and solutions leadership. "Ariel is a proven marketing leader with deep experi

    2/9/26 2:00:00 PM ET
    $AMD
    Semiconductors
    Technology

    Edgewater Wireless Issues 2026 Corporate Update

    "Wi-Fi8 Before Wi-Fi8" – Accelerating Wi-Fi8-ready Spectrum Slicing™ Silicon with Silicon Catalyst Ecosystem, Arm, Synopsys and FABrIC Support Edgewater Wireless Systems Inc. (TSXV:YFI) (OTC:KPIFF), the industry pioneer of AI-powered Wi-Fi Spectrum Slicing™ silicon solutions and IP for residential, enterprise and Industrial IoT markets, today issued a corporate update outlining the Company's material progress over the past 12 months and its 2026 execution roadmap toward Wi-Fi8-ready silicon deliverables and strategic commercialization. Over the last year, Edgewater has evolved from an innovation-led Wi-Fi disruptor into a globally recognized reliability and low-latency thought leader, a

    2/5/26 7:01:00 AM ET
    $ARM
    $SNPS
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    J.P. Morgan Asset Management Welcomes Pam Hess as Retirement Strategist

    Experienced retirement research expert to help meet increased demand for actionable retirement insights NEW YORK, Jan. 27, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the appointment of Pam Hess as Executive Director and Retirement Strategist on the Retirement Insights team reporting to Michael Conrath, Chief Retirement Strategist. This key hire reflects the firm's ongoing commitment to investing in resources that help financial professionals, participants and plan sponsors navigate today's complex retirement landscape. In this role, Pam supports the deve

    1/27/26 10:00:00 AM ET
    $JPM
    Major Banks
    Finance

    $ALB
    $AMD
    $ARM
    $AVGO
    Financials

    Live finance-specific insights

    View All

    24 Merrill Advisors Recognized on Financial Planning's Top 40 Brokers Under 40 List

    Merrill Leads List With Most Advisors Named for Seventh Consecutive YearNEW YORK, Feb. 20, 2026 /PRNewswire/ -- Financial Planning recognized 24 Merrill Wealth Management and Merrill Private Wealth Advisors on its annual Top 40 Brokers Under 40. For the seventh consecutive year, Merrill has had more advisors on the list than any other firm underscoring the strength of Merrill's talent and the company's commitment to advisor development at every stage of their careers. (Rankings published February 10, 2026, based on data as of September 30, 2025.) "We're proud of these advisors a

    2/20/26 9:00:00 AM ET
    $BAC
    Major Banks
    Finance

    Wells Fargo Updates 2026 Earnings Release Date Information

    Wells Fargo & Company (NYSE:WFC) today updated its expected earnings release dates and conference call information for 2026. For each of the earnings dates below, financial results will be released at approximately 7:00 a.m. Eastern time, and the live conference call will be at 10:00 a.m. Eastern time. Confirmation of these calls, as well as details on how to listen, will be provided before the scheduled release dates. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260220255811/en/Exterior view of a Wells Fargo branch along a city sidewalk with trees and passing traffic. (Photo: Wells Fargo) Expected earnings release dates for 2

    2/20/26 8:00:00 AM ET
    $WFC
    Major Banks
    Finance

    New BofA Rewards™ Program to Reach Millions More Clients with Expanded Benefits

    No Fee Loyalty Program1 Available to Any Client with a Personal Checking AccountMore Than 30 Million Clients Newly Qualify for Personalized RewardsNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Bank of America today announced plans to launch BofA Rewards, a no fee loyalty program designed to reward and recognize clients for their full relationship across their Bank of America banking and Merrill investing accounts. Starting May 27, millions of clients can enroll in the new program to unlock benefits on eligible credit cards, cash back deals, banking services, curated experiences and more. BofA Rewards members can benefit from $150 to $4,000 in annual value based on their membership tier and program

    2/18/26 1:58:00 PM ET
    $BAC
    Major Banks
    Finance